CoreWeave, Inc. (CRWV) is a U.S.-listed AI cloud infrastructure company — a "neocloud" provider of GPU compute for training and running artificial intelligence models. Because it has broad sell-side coverage, the central target here is built from individual analyst price targets rather than any single headline figure.
Across roughly 18 distinct, current analyst targets with identifiable firms and dates, the targets range from a low of $39 (HSBC, Sell) to a high of $278, with a calculated arithmetic mean of about $138, rounded to a $140 central target. Independent data providers report consensus figures in a similar band — roughly $130 to $144 — reflecting a wide spread. The rating mix leans bullish, but the spread between a $39 target and a $278 target is extreme, and no single number should be treated as a forecast.
Recent target changes illustrate the divide. Barclays (Hold) set $105, Goldman Sachs (Buy) trimmed to $106, JPMorgan (Overweight) held $125, Bank of America (Buy) kept $140, Oppenheimer and Evercore both stood at $150, Cantor Fitzgerald held $176, and Northland raised its target to $200. On the cautious side, Morgan Stanley moved to Hold with a $70 target, Raymond James cut its Buy target to $75, Bernstein stayed at Underperform, and HSBC reiterated Sell at $39.
CoreWeave shares have traded in roughly the $54 to $64 range during late October, well below a 52-week high around $140. Using a recent price near $62, the move to $140 represents upside of more than 120% — a very large move by any standard, not a modest step toward a nearby level.
The path is fundamentally about capital. CoreWeave reported quarterly revenue of about $2.6 billion (up from roughly $1.2 billion a year earlier) alongside a GAAP net loss, and it carries a substantial debt load to fund its data-center buildout. Bulls argue the company's contracted backlog — measured in the tens to over $100 billion — and strong pricing support a much higher equity value. Bears argue that financing costs, dilution, and heavy capital expenditure could consume much of that value before it reaches shareholders.
Several verified factors underpin the bullish case. Demand for AI compute remains strong, and CoreWeave has pre-sold most of the capacity expected to come online in 2027, with a reported agreement from Nvidia (NVDA) to purchase unused compute capacity. Management has raised 2026 revenue guidance, and analysts including JPMorgan have pointed to rising prices and improving contract margins as offsets to higher funding costs. The company's software stack — including its Forge offering — is cited by firms such as Compass Point and Oppenheimer as a differentiator that could support retention and pricing even as GPU supply grows. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The principal obstacle is the balance sheet. CoreWeave's expansion is funded largely with debt, and its bonds have sold off sharply, with yields on some notes nearing the mid-teens as investors weigh GPU obsolescence and refinancing risk. Goldman Sachs has sized additional financing needs in the tens of billions of dollars, and Bernstein has estimated even larger requirements. Sustained dilution through an at-the-market equity program, insider selling, and the risk that new competitor capacity drives down pricing could all compress the multiple investors are willing to pay — which is precisely the scenario reflected in the lowest targets.
The technical backdrop reinforces how demanding the target is. The $140 level sits right at the stock's prior 52-week high — in other words, the target coincides with an area that previously marked a top and a reversal point. On the downside, the $51–$54 zone around the recent 52-week lows is the key support area to watch; a decisive break below it would signal renewed selling pressure, while a sustained move back above roughly $70–$75 would be an early sign that the downtrend is stabilizing.
Analyst price targets typically reflect a research horizon of roughly 12 months, though individual firms rarely disclose identical timeframes, and the wide target range here suggests very different assumptions about the same 12-month period. The most important upcoming items are CoreWeave's next quarterly earnings report, management's updated revenue and margin guidance, any new financing or delayed-draw term loan announcements, and changes in the company's bond yields as a gauge of credit-market confidence. Analyst target revisions — which have been frequent and large — will remain a key signal of how the financing debate is resolving.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like CoreWeave, where sentiment and financing headlines can shift quickly, these signals offer traders a systematic way to discover opportunities, monitor positions, and spot changing trends more efficiently than manual review alone. I find them particularly useful when cross-checking analyst views against real-time technical shifts.
Can CoreWeave stock reach $140? The question hinges less on demand — which is broadly acknowledged to be strong — than on whether the company can fund its expansion without meaningfully diluting shareholders or buckling under debt costs. The $140 central target, a rounded average of roughly 18 analyst targets ranging from $39 to $278, requires a move of more than 120% from recent prices, making it a very large ask tied to a prior high. Bulls point to a contracted backlog, pricing power, and a differentiated software layer; bears point to leverage, dilution, obsolescence, and intensifying competition. There is no consensus on the outcome — only a wide range of views. Investors should watch earnings, guidance, and credit-market signals closely rather than treat any single target as a destination.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
The RSI Oscillator for CRWV moved out of oversold territory on October 27, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 7 similar instances when the indicator left oversold territory. In 7 of the 7 cases the stock moved higher. This puts the odds of a move higher at 90%.
The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. 19 of 19 cases where CRWV's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are 90%.
Following a +15.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where CRWV advanced for three days, in 80 of 88 cases, the price rose further within the following month. The odds of a continued upward trend are 90%.
CRWV may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.
The Momentum Indicator moved below the 0 level on October 08, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on CRWV as a result. In 20 of 21 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 90%.
The Moving Average Convergence Divergence Histogram (MACD) for CRWV turned negative on October 08, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 15 similar instances when the indicator turned negative. In 14 of the 15 cases the stock turned lower in the days that followed. This puts the odds of success at 90%.
CRWV moved below its 50-day moving average on October 08, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for CRWV crossed bearishly below the 50-day moving average on October 08, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In 5 of 5 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are 90%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CRWV declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 90%.
The Tickeron PE Growth Rating for this company is 26 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of 40 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (7.018) is normal, around the industry mean (15.971). P/E Ratio (-18.008) is within average values for comparable stocks, (60.982). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (3.648). Dividend Yield (0.000) settles around the average of (0.208) among similar stocks. P/S Ratio (5.721) is also within normal values, averaging (103.889).
The Tickeron Price Growth Rating for this company is 84 (best 1 - 100 worst), indicating slightly worse than average price growth. CRWV’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron SMR rating for this company is 98 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CRWV’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 91, placing this stock worse than average.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry ComputerCommunications